Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

SK Biopharmaceuticals

Tracked across 6 events · 37 articles · First seen Jul 13, 2026 · Last active Sep 10, 2026

Sentiment
35
Attention
4
Events
6
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 70
Business
Impact: Sino Biopharmaceutical is the central entity, announcing its new global brand and highlighting its globalization strategy. The company's licensing deals and brand launch are expected to strengthen its market position and investor sentiment.
Jul 20, 2026 · 6 articles
4 80
Business
Impact: Caliway is the developer of CBL-514 and the primary beneficiary. FDA clearance and Phase 3 enrollment advance its pipeline, potentially leading to the first non-surgical fat reduction drug, which could significantly increase its market value.
Jul 20, 2026 · 7 articles
4 15
Business
Impact: SK Biopharmaceuticals recently partnered with Cipla on a different oncology asset, highlighting Cipla's strategy of in-licensing from Chinese firms.
Sep 03, 2026 · 6 articles
2 40
Business
Impact: Collaboration partner; contributes to Insilico's revenue growth, but no direct impact from index inclusion.
Jul 20, 2026 · 6 articles
3 0
Business
Impact: SK Biopharmaceuticals is mentioned as a prior collaborator with Insilico, but is not directly involved in this event.
Jul 13, 2026 · 6 articles
4 5
Tech
Insilico Medicine announced on September 9-10, 2026 that it has dosed the first patient with Rentosertib (ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial for idiopathic pulmonary fibrosis (IPF), at United Medical College…
Impact: SK Biopharmaceuticals is listed among Insilico's collaboration partners. The event has minimal direct impact on SK Biopharmaceuticals.
Sep 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track SK Biopharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.